Pediatric diabetes mellitus hospitalizations and COVID-19 pandemic response measures

被引:0
|
作者
Shimony, Hope [1 ]
Miller, Lauren [1 ]
Reich, Patrick [2 ]
Banull, Nicholas R. [1 ]
Burch, Maureen [3 ]
Bryan, Melanie [1 ]
Arbelaez, Ana Maria [1 ,4 ]
机构
[1] Washington Univ, Pediat Endocrinol, Sch Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Pediat Infect Dis, St Louis, MO 63110 USA
[3] St Louis Childrens Hosp, Certified Diabet Educ Program, St Louis, MO USA
[4] Washington Univ, Pediat Endocrinol & Diabet Div, Sch Med, 660 South Euclid, Campus Box 8116, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Diabetes Mellitus; Children; COVID-19; Diabetic Ketoacidosis; Social Vulnerability; UNITED-STATES; SARS-COV-2; SEROPREVALENCE; CHILDREN; VACCINE; TYPE-1; TRENDS;
D O I
10.1016/j.diabres.2023.111060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: In the United States, evidence suggests that during the COVID-19 pandemic, admissions of patients with diabetes mellitus (DM) have increased. This study assessed hospital admission rates for pediatric type 1 (T1DM) and type 2 (T2DM) diabetes mellitus during 2019-2021, and the potential influence of the timing of various pandemic response measures. Methods: Retrospective chart reviews were conducted of 854 T1DM and 135 T2DM hospital admissions between January 2019 and December 2021 in patients < 20 years old to collect demographic data, admission type, body mass index (BMI), and area deprivation index (ADI, a measure of socioeconomic vulnerability). Patients were divided into three cohorts based on their admission year: 2019 (Pre-pandemic), 2020 (Pandemic, Pre-vaccine), and 2021 (Pandemic, Post-vaccine). Admissions were categorized within each cohort by diagnosis (T1DM or T2DM) and clinical presentation (new onset, diabetic ketoacidosis: DKA). Cohorts were compared using an independent samples t-test for continuous variables or a chi-square test for categorical variables. Results: The incidence of T2DM hospitalizations tripled during the pandemic, increasing from 18 in 2019 (Prepandemic), to 55 in 2020 (Pandemic, Pre-vaccine), and 62 in 2021 (Pandemic, Post-vaccine). The rate of patients presenting with DKA was 15.4 % (95 % CI: 4 %-26.9 %) higher in 2020 (Pandemic, Pre-vaccine) among patients with new-onset T1DM (72/139 vs. 52/143), and 22.5 % (95 % CI: 9.6 %-35.4 %) higher in 2020 (Pandemic, Prevaccine) among T2DM patients (9/40 vs. 0/14). This increased rate of new onset T2DM significantly correlated with younger age (P = 0.046) and higher ADI score (P = 0.017), but not with BMI. Conclusion: The incidence of T1DM hospitalizations did not increase during the pandemic; however, they tripled for T2DM patients. All new onset DM pediatric patients during the pandemic were more likely to present in DKA. Patients admitted with new onset T2DM were socioeconomically more vulnerable. For T1DM, the peak of local pediatric diabetes admissions in 2020 occurred slightly later coinciding with the reopening of primary care physicians (PCP) offices and schools.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Pediatric Respiratory Syncytial Virus Hospitalizations and Respiratory Support After the COVID-19 Pandemic
    Winthrop, Zachary A.
    Perez, Jennifer M.
    Staffa, Steven J.
    McManus, Michael L.
    Duvall, Melody G.
    JAMA NETWORK OPEN, 2024, 7 (06) : e2416852
  • [32] Cardiovascular Hospitalizations, Influenza Activity, and COVID-19 Measures
    Myhre, Peder L.
    Grundvold, Irene
    Paulsen, Trine H.
    Omland, Torbjorn
    Schirmer, Henrik
    CIRCULATION, 2020, 142 (13) : 1302 - 1304
  • [33] COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic
    Faruqi, Jordana
    Balasubramanyam, Ashok
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2023, 18 (02) : 167 - 179
  • [34] The effect of the COVID-19 pandemic on hospitalizations of cirrhotic patients
    Sinatti, G.
    Cosimini, B.
    Braicu, A. . A. .
    Santini, S. Jr.
    Caputo, V.
    Ruscitti, A.
    Mammarella, L.
    Balsano, C.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S324 - S324
  • [35] Trends in cirrhosis hospitalizations during the COVID-19 pandemic
    Gaspar, R.
    Liberal, R.
    Branco, Catarina Castelo
    Macedo, G.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (09) : 942 - 943
  • [36] Impact of the COVID-19 pandemic on heart failure hospitalizations
    Burgos, Lucrecia M.
    Diez, Mirta
    Villalba, Lorena
    Miranda, Rita M.
    Belardi, Jorge
    MEDICINA-BUENOS AIRES, 2020, 80 (03) : 315 - 316
  • [37] THE IMPACT OF THE COVID-19 PANDEMIC ON HOSPITALIZATIONS FOR DIVERTICULAR DISEASE
    Germana', B.
    Amidei, Barbiellini C.
    Bellio, S.
    Saia, M.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S87 - S87
  • [38] Hospitalizations for sarcoidosis in Poland: impact of the COVID-19 pandemic
    Mejza, Filip
    Mastalerz, Lucyna
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (01):
  • [39] The Australian response to the COVID-19 pandemic and diabetes - Lessons learned
    Andrikopoulos, Sof
    Johnson, Greg
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 165
  • [40] Hospitalizations for Hyperglycemic Crisis during COVID-19 Pandemic
    Riaz, Aiman
    Gordner, Chelsea
    Ehresman, Alice
    DIABETES, 2021, 70